AChR Myasthenia Gravis
4 clinical trials · Condition
◉ Watch AChR Myasthenia Gravis
| Record | Firm | Date |
|---|---|---|
| Long Term Safety Study of Amifampridine Phosphate in MuSK-MG (Muscle Specific Tyrosine Kinase Myasthenia Gravis) (NCT03579966) | Catalyst Pharmaceuticals, Inc. | 2018-06-11 |
Track AChR Myasthenia Gravis automatically
Every clearance here is in the API, with alerts when new ones post.